<DOC>
	<DOC>NCT00806494</DOC>
	<brief_summary>To explore the effects of fesoterodine when used in a flexible dose manner</brief_summary>
	<brief_title>UK Study Assessing Flexible Dose Fesoterodine in Adults</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Fesoterodine</mesh_term>
	<criteria>Male or female &gt;18 years old OAB for &gt;3 months Patients with conditions that would contraindicate for fesoterodine use Patients with significant hepatic and renal disease or other significant unstable diseases. OAB symptoms caused by neurological conditions, known pathologies of urinary tract, etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Fesoterodine</keyword>
	<keyword>Open Label</keyword>
	<keyword>Flexible Dose</keyword>
	<keyword>OAB</keyword>
</DOC>